Repurposing Ilaprazole as a PP5 TPR Domain Binder with Modulatory Effects on MAPK Signaling. [PDF]
He Y +8 more
europepmc +1 more source
Clinical pharmacist-led prevention of intravenous drug incompatibilities in an adult ICU: a prospective observational study. [PDF]
Kayra T +4 more
europepmc +1 more source
Safety of intravenous pantoprazole sodium in paediatric patients aged 1 year to <2 years: a real-world retrospective cohort study in the USA. [PDF]
Gandhi SK +5 more
europepmc +1 more source
A Comparison of the Efficacy and Tolerability of Quinolone-Based Triple Therapy, Quadruple Therapy, and High-Dose Amoxicillin Therapy in <i>Helicobacter pylori</i> Eradication. [PDF]
Atasoy H +6 more
europepmc +1 more source
COVID-19 infection in kidney transplant recipients [PDF]
Banerjee, D +5 more
core +1 more source
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion. [PDF]
Santos ACD +10 more
europepmc +1 more source
Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trials. [PDF]
Al Hayek M +11 more
europepmc +1 more source
The Effect of Pantoprazole on Midline Closure in Early Chicken Embryos: An Experimental Study. [PDF]
Turkoglu H +4 more
europepmc +1 more source
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Almabruk BA +8 more
europepmc +1 more source
Proton Pump Inhibitor Use for Gastroprotection and Stress Ulcer Prophylaxis Does Not Increase the Risk of <i>Clostridioides difficile</i> Infection or Pneumonia: A Systematic Review and Meta-Analysis of RCTs. [PDF]
Omar MA +6 more
europepmc +1 more source

